论文部分内容阅读
目的 :采用双模拟随机双盲对照法观察通心络胶囊治疗冠心病心绞痛的临床疗效。方法 :分为治疗组和对照组 ,每组 30例 ,疗程 4周。结果 :心绞痛疗效 :治疗组和对照组显效率分别为 6 3 33%和 30 % ,总有效率分别为 96 6 7%和 73 33% (P <0 0 1) ;心电图疗效 :治疗组和对照组显效率分别为 30 %和 16 6 7% ,总有效率分别为70 %和 43 33% (P <0 0 5 ) ;临床主要症状疗效 :治疗组和对照组显效率分别为 6 3 33%和 2 6 6 7% ,总有效率分别为 96 6 7%和 73 33% (P <0 0 1) ;另外在治疗前后心绞痛发作情况、硝酸甘油停减率、总疗效等方面亦以治疗组为优。结论 :通心络胶囊治疗冠心病心绞痛具有较好疗效
Objective: To observe the clinical effect of Tongxinluo Capsule in the treatment of angina pectoris with double-blind randomized double-blind comparison. Methods: Divided into treatment group and control group, each group 30 cases, treatment for 4 weeks. Results: The efficacy of angina pectoris: The effective rates of the treatment group and the control group were respectively 6 33.3% and 30%, the total effective rates were 96 6 7% and 73 33% respectively (P 0 01) The total effective rates were 30% and 16 6%, respectively, and the total effective rates were 70% and 43 33%, respectively (P 0 05). The main clinical symptoms and signs were markedly effective in the treatment group and the control group, which were respectively 63 33% And 26 6 7%, respectively. The total effective rates were 96 6 7% and 73 33% respectively (P 0 01). In addition, the incidence of angina pectoris, the rate of reduction of nitroglycerin, the total curative effect, Excellent. Conclusion: Tongxinluo capsule is effective in treating angina pectoris of coronary heart disease